{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,8]],"date-time":"2024-05-08T00:14:19Z","timestamp":1715127259133},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2024,3,8]],"date-time":"2024-03-08T00:00:00Z","timestamp":1709856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,3,8]],"date-time":"2024-03-08T00:00:00Z","timestamp":1709856000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1245\/s10434-024-15104-3","type":"journal-article","created":{"date-parts":[[2024,3,8]],"date-time":"2024-03-08T19:02:00Z","timestamp":1709924520000},"page":"3964-3971","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The Role of Demographic and Clinical Factors in Germline Mutation Testing for Patients with Primary Hyperparathyroidism"],"prefix":"10.1245","volume":"31","author":[{"given":"Patrick T.","family":"Hangge","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophie","family":"Dream","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tina W. F.","family":"Yen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kara","family":"Doffek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samantha M.","family":"Stachowiak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Shaker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Douglas B.","family":"Evans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tracy S.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,3,8]]},"reference":[{"issue":"8","key":"15104_CR1","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1007\/s00423-015-1342-7","volume":"400","author":"M Iacobone","year":"2015","unstructured":"Iacobone M, Carnaille B, Palazzo FF, Vriens M. Hereditary hyperparathyroidism\u2014A consensus report of the European society of endocrine surgeons (ESES). Langenbeck\u2019s Arch Surg. 2015;400(8):867\u201386. https:\/\/doi.org\/10.1007\/s00423-015-1342-7.","journal-title":"Langenbeck's Arch Surg."},{"issue":"2","key":"15104_CR2","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.ecl.2017.01.006","volume":"46","author":"WF Simonds","year":"2017","unstructured":"Simonds WF. Genetics of hyperparathyroidism, including parathyroid cancer. Endocrinol Metab Clin North Am. 2017;46(2):405\u201318. https:\/\/doi.org\/10.1016\/j.ecl.2017.01.006.","journal-title":"Endocrinol Metab Clin North Am."},{"issue":"5","key":"15104_CR3","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/j.beem.2018.05.004","volume":"32","author":"JY Lee","year":"2018","unstructured":"Lee JY, Shoback DM. Familial hypocalciuric hypercalcemia and related disorders. Best Pract Res Clin Endocrinol Metab. 2018;32(5):609\u201319. https:\/\/doi.org\/10.1016\/j.beem.2018.05.004.","journal-title":"Best Pract Res Clin Endocrinol Metab."},{"issue":"11","key":"15104_CR4","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1002\/jbmr.4677","volume":"37","author":"JP Bilezikian","year":"2022","unstructured":"Bilezikian JP, Khan AA, Silverberg SJ, et al. Evaluation and management of primary hyperparathyroidism: summary statement and guidelines from the fifth international workshop. J Bone Miner Res. 2022;37(11):2293\u2013314. https:\/\/doi.org\/10.1002\/jbmr.4677.","journal-title":"J Bone Miner Res."},{"issue":"2","key":"15104_CR5","doi-asserted-by":"publisher","first-page":"R33","DOI":"10.1530\/eje-21-1044","volume":"186","author":"J Bollerslev","year":"2022","unstructured":"Bollerslev J, Rejnmark L, Zahn A, et al. European expert consensus on practical management of specific aspects of parathyroid disorders in adults and in pregnancy: recommendations of the ESE Educational Program of Parathyroid Disorders (PARAT 2021). European J Endocrinol. 2022;186(2):R33\u201363. https:\/\/doi.org\/10.1530\/eje-21-1044.","journal-title":"European J Endocrinol."},{"issue":"10","key":"15104_CR6","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1001\/jamasurg.2016.2310","volume":"151","author":"SM Wilhelm","year":"2016","unstructured":"Wilhelm SM, Wang TS, Ruan DT, et al. The American association of endocrine surgeons guidelines for definitive management of primary hyperparathyroidism. JAMA Surg. 2016;151(10):959\u201368. https:\/\/doi.org\/10.1001\/jamasurg.2016.2310.","journal-title":"JAMA Surg."},{"issue":"10","key":"15104_CR7","doi-asserted-by":"publisher","first-page":"3570","DOI":"10.1210\/jc.2014-1414","volume":"99","author":"R Eastell","year":"2014","unstructured":"Eastell R, Brandi ML, Costa AG, D\u2019Amour P, Shoback DM, Thakker RV. Diagnosis of asymptomatic primary hyperparathyroidism: proceedings of the Fourth international workshop. J Clin Endocrinol Metab. 2014;99(10):3570\u20139. https:\/\/doi.org\/10.1210\/jc.2014-1414.","journal-title":"J Clin Endocrinol Metab."},{"issue":"11","key":"15104_CR8","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1210\/jc.2013-4491","volume":"99","author":"T Lassen","year":"2014","unstructured":"Lassen T, Friis-Hansen L, Rasmussen \u212bK, Knigge U, Feldt-Rasmussen U. Primary hyperparathyroidism in young people. When should we perform genetic testing for multiple endocrine neoplasia 1 (MEN-1)? J Clin Endocrinol Metab. 2014;99(11):983\u20133987. https:\/\/doi.org\/10.1210\/jc.2013-4491.","journal-title":"J Clin Endocrinol Metab."},{"issue":"2","key":"15104_CR9","doi-asserted-by":"publisher","first-page":"E403","DOI":"10.1210\/jc.2012-2789","volume":"98","author":"L Bricaire","year":"2013","unstructured":"Bricaire L, Odou M-F, Cardot-Bauters C, et al. Frequent large germline HRPT2 deletions in a French national cohort of patients with primary hyperparathyroidism. J Clin Endocrinol Metab. 2013;98(2):E403\u20138. https:\/\/doi.org\/10.1210\/jc.2012-2789.","journal-title":"J Clin Endocrinol Metab."},{"issue":"4","key":"15104_CR10","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1007\/s10897-016-0064-5","volume":"26","author":"S Hayden","year":"2017","unstructured":"Hayden S, Mange S, Duquette D, Petrucelli N, Raymond VM. Large, prospective analysis of the reasons patients do not pursue BRCA genetic testing following genetic counseling. J Genet Couns. 2017;26(4):859\u201365. https:\/\/doi.org\/10.1007\/s10897-016-0064-5.","journal-title":"J Genet Couns."},{"issue":"1","key":"15104_CR11","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1002\/jgc4.1459","volume":"31","author":"GA Lin","year":"2022","unstructured":"Lin GA, Trosman JR, Douglas MP, et al. Influence of payer coverage and out-of-pocket costs on ordering of NGS panel tests for hereditary cancer in diverse settings. J Genet Couns. 2022;31(1):130\u20139. https:\/\/doi.org\/10.1002\/jgc4.1459.","journal-title":"J Genet Couns."},{"issue":"5","key":"15104_CR12","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/j.jamcollsurg.2018.01.007","volume":"226","author":"M El Lakis","year":"2018","unstructured":"El Lakis M, Nockel P, Gaitanidis A, et al. Probability of positive genetic testing results in patients with family history of primary hyperparathyroidism. J Am Coll Surg. 2018;226(5):933\u20138. https:\/\/doi.org\/10.1016\/j.jamcollsurg.2018.01.007.","journal-title":"J Am Coll Surg."},{"key":"15104_CR13","doi-asserted-by":"publisher","DOI":"10.3410\/m2-14","author":"A Falchetti","year":"2010","unstructured":"Falchetti A. Genetic screening for multiple endocrine neoplasia syndrome type 1 (MEN-1): when and how. F1000 Med Rep. 2010. https:\/\/doi.org\/10.3410\/m2-14.","journal-title":"F1000 Med Rep."},{"issue":"2","key":"15104_CR14","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1111\/j.1365-2265.2005.02190.x","volume":"62","author":"S Ellard","year":"2005","unstructured":"Ellard S, Hattersley A, Brewer C, Vaidya B. Detection of an MEN1 gene mutation depends on clinical features and supports current referral criteria for diagnostic molecular genetic testing. Clin Endocrinol. 2005;62(2):169\u201375.","journal-title":"Clin Endocrinol."},{"issue":"9","key":"15104_CR15","doi-asserted-by":"publisher","first-page":"3389","DOI":"10.1210\/jc.2007-0476","volume":"92","author":"E Tham","year":"2007","unstructured":"Tham E, Grandell U, Lindgren E, Gr T, Skogseid B, Nordenskj\u00f6ld M. Clinical testing for mutations in the MEN1 gene in Sweden: a report on 200 unrelated cases. J Clin Endocrinol Metab. 2007;92(9):3389\u201395. https:\/\/doi.org\/10.1210\/jc.2007-0476.","journal-title":"J Clin Endocrinol Metab."},{"issue":"4","key":"15104_CR16","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1111\/cen.14254","volume":"93","author":"S Mariathasan","year":"2020","unstructured":"Mariathasan S, Andrews KA, Thompson E, et al. Genetic testing for hereditary hyperparathyroidism and familial hypocalciuric hypercalcaemia in a large UK cohort. Clin Endocrinol. 2020;93(4):409\u201318. https:\/\/doi.org\/10.1111\/cen.14254.","journal-title":"Clin Endocrinol."},{"issue":"1\u20132","key":"15104_CR17","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1007\/s12672-011-0100-8","volume":"3","author":"LF Starker","year":"2012","unstructured":"Starker LF, Akerstr\u00f6m T, Long WD, et al. Frequent germ-line mutations of the MEN1, CASR, and HRPT2\/CDC73 genes in young patients with clinically non-familial primary hyperparathyroidism. Horm Cancer. 2012;3(1\u20132):44\u201351. https:\/\/doi.org\/10.1007\/s12672-011-0100-8.","journal-title":"Horm Cancer."},{"key":"15104_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.853171","volume":"13","author":"HS Park","year":"2022","unstructured":"Park HS, Lee YH, Hong N, Won D, Rhee Y. Germline mutations related to primary hyperparathyroidism identified by next-generation sequencing. Front Endocrinol (Lausanne). 2022;13:853171. https:\/\/doi.org\/10.3389\/fendo.2022.853171.","journal-title":"Front Endocrinol (Lausanne)."},{"issue":"6","key":"15104_CR19","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1016\/j.ajhg.2020.04.006","volume":"106","author":"R Dershem","year":"2020","unstructured":"Dershem R, Gorvin CM, Metpally RPR, et al. Familial hypocalciuric hypercalcemia type 1 and autosomal-dominant hypocalcemia type 1: prevalence in a large healthcare population. Am J Hum Genet. 2020;106(6):734\u201347. https:\/\/doi.org\/10.1016\/j.ajhg.2020.04.006.","journal-title":"Am J Hum Genet."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-024-15104-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-024-15104-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-024-15104-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,7]],"date-time":"2024-05-07T13:07:03Z","timestamp":1715087223000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-024-15104-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,8]]},"references-count":19,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["15104"],"URL":"https:\/\/doi.org\/10.1245\/s10434-024-15104-3","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,8]]},"assertion":[{"value":"13 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"No disclosures of any commercial interest for all authors involved","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}